Establishment of ATP-Based Luciferase Viability Assay in 96-Well Plate for Trypanosoma congolense
-
- SUGANUMA Keisuke
- National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro, Hokkaido 080–8555, Japan
-
- ALLAMANDA Puttik
- National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro, Hokkaido 080–8555, Japan Disease Investigation Center (DIC) Subang, West Java 41212, Indonesia
-
- HAKIMI Hassan
- National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro, Hokkaido 080–8555, Japan Department of Protozoology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Sakamoto, Nagasaki 852–8523, Japan
-
- ZHOU Mo
- National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro, Hokkaido 080–8555, Japan
-
- ANGELES Jose Ma.
- National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro, Hokkaido 080–8555, Japan
-
- KAWAZU Shin-ichiro
- National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro, Hokkaido 080–8555, Japan
-
- INOUE Noboru
- National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro, Hokkaido 080–8555, Japan
書誌事項
- タイトル別名
-
- Establishment of ATP-Based Luciferase Viability Assay in 96-Well Plate for <i>Trypanosoma congolense</i>
- Parasitology : Establishment of ATP-Based Luciferase Viability Assay in 96-Well Plate for Trypanosoma congolense
この論文をさがす
説明
Animal African trypanosomosis (AAT), caused by Trypanosoma congolense, is widespread throughout sub-Saharan Africa. There are significant concerns related to the current drugs available for the treatment of AAT due to their limited effectiveness across species and their adverse effects. Moreover, drug resistant trypanosomes have recently been reported in the field. High throughput screening (HTS) of large chemical compound library collections is a promising approach for identifying novel drug candidates. While HTS for Trypanozoon trypanosomes, T. brucei sspp. and T. evansi is well established, no assays have been developed for T. congolense. In the present study, the authors developed an ATP-based luciferase viability assay for T. congolense in a 96-well plate format. The calculated 50% inhibitory concentration (IC50) values for pentamidine and diminazene were 10–100 times higher in T. congolense than in T. brucei. This result suggests that the transporters for the 2 tested compounds differ between T. congolense and T. brucei. This assay could further be applied to screen novel chemical compounds for the treatment of AAT caused by T. congolense.
収録刊行物
-
- The Journal of Veterinary Medical Science
-
The Journal of Veterinary Medical Science 76 (11), 1437-1441, 2014
公益社団法人 日本獣医学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681404863104
-
- NII論文ID
- 130004704128
-
- NII書誌ID
- AA10796138
-
- ISSN
- 13477439
- 09167250
-
- HANDLE
- 10069/34999
-
- NDL書誌ID
- 025935611
-
- PubMed
- 25056575
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- IRDB
- NDLサーチ
- Crossref
- PubMed
- CiNii Articles
- KAKEN
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可